Mammalian target of rapamycin pathway mutations cause hemimegalencephaly and focal cortical dysplasia

Publisher： John Wiley & Sons Inc

E-ISSN： 1531-8249|77|4|720-725

ISSN： 0364-5134

Source： ANNALS OF NEUROLOGY, Vol.77, Iss.4, 2015-04, pp. : 720-725

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 44, Iss. 1, 2018-02 ,pp. : 6-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb

By  

ANNALS OF NEUROLOGY, Vol. 78, Iss. 3, 2015-09 ,pp. : 375-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Familial focal epilepsy with focal cortical dysplasia due to DEPDC5 mutations

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 4, 2015-04 ,pp. : 675-683

John Wiley & Sons Inc

Access to resources Recommend Favorite

Reply: HPV in focal cortical dysplasia

By  

ANNALS OF NEUROLOGY, Vol. 77, Iss. 2, 2015-02 ,pp. : 353-353

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pathogenetic mechanisms of focal cortical dysplasia

By  

EPILEPSIA, Vol. 55, Iss. 7, 2014-07 ,pp. : 970-978

John Wiley & Sons Inc

Access to resources Recommend Favorite